.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Fish and Richardson
McKesson
Accenture
US Army
Novartis
UBS
McKinsey
Teva
Moodys

Generated: December 16, 2017

DrugPatentWatch Database Preview

Tersera Therap Company Profile

« Back to Dashboard

What is the competitive landscape for TERSERA THERAP, and when can generic versions of TERSERA THERAP drugs launch?

TERSERA THERAP has three approved drugs.

There are three US patents protecting TERSERA THERAP drugs.

There are forty-seven patent family members on TERSERA THERAP drugs in thirty-three countries.

Summary for Tersera Therap

International Patents:47
US Patents:3
Tradenames:2
Ingredients:2
NDAs:3
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tersera Theraps LlcERGOMARergotamine tartrateTABLET;SUBLINGUAL087693-001Feb 24, 1983RXNoYes► Subscribe► Subscribe► Subscribe
Tersera Theraps LlcZOLADEXgoserelin acetateIMPLANT;IMPLANTATION020578-001Jan 11, 1996RXYesYes► Subscribe► SubscribeY► Subscribe
Tersera Theraps LlcZOLADEXgoserelin acetateIMPLANT;IMPLANTATION020578-001Jan 11, 1996RXYesYes► Subscribe► SubscribeY► Subscribe
Tersera Theraps LlcZOLADEXgoserelin acetateIMPLANT;IMPLANTATION019726-001Dec 29, 1989RXYesYes► Subscribe► SubscribeY► Subscribe
Tersera Theraps LlcZOLADEXgoserelin acetateIMPLANT;IMPLANTATION019726-001Dec 29, 1989RXYesYes► Subscribe► SubscribeY► Subscribe
Tersera Theraps LlcZOLADEXgoserelin acetateIMPLANT;IMPLANTATION019726-001Dec 29, 1989RXYesYes► Subscribe► SubscribeY► Subscribe
Tersera Theraps LlcZOLADEXgoserelin acetateIMPLANT;IMPLANTATION020578-001Jan 11, 1996RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tersera Therap

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Tersera Theraps LlcZOLADEXgoserelin acetateIMPLANT;IMPLANTATION020578-001Jan 11, 1996► Subscribe► Subscribe
Tersera Theraps LlcZOLADEXgoserelin acetateIMPLANT;IMPLANTATION019726-001Dec 29, 1989► Subscribe► Subscribe
Tersera Theraps LlcZOLADEXgoserelin acetateIMPLANT;IMPLANTATION020578-001Jan 11, 1996► Subscribe► Subscribe
Tersera Theraps LlcZOLADEXgoserelin acetateIMPLANT;IMPLANTATION020578-001Jan 11, 1996► Subscribe► Subscribe
Tersera Theraps LlcZOLADEXgoserelin acetateIMPLANT;IMPLANTATION019726-001Dec 29, 1989► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tersera Therap Drugs

Country Document Number Estimated Expiration
Canada2398066► Subscribe
Brazil0108460► Subscribe
Taiwan500616► Subscribe
Bulgaria65506► Subscribe
Japan4699192► Subscribe
Bulgaria106938► Subscribe
Hungary0204198► Subscribe
Austria344075► Subscribe
Iceland6493► Subscribe
Japan2006116339► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Fish and Richardson
Moodys
Johnson and Johnson
Queensland Health
Express Scripts
Dow
Deloitte
AstraZeneca
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot